Clinical-epidemiological profile of drug intoxication in children
DOI:
https://doi.org/10.47456/rbps.v22i3.27642Keywords:
Exogenous Intoxication, Drugs, Child, Descriptive EpidemiologyAbstract
Introduction: Childhood poisoning is a common and preventable cause of morbidity and mortality in several countries. The significant increase in the incidence of cases associated with risks makes this disease very relevant in this age group. Objective: to describe the clinical-epidemiological profile of reported cases of drug intoxication in children. Methods: Observational and descriptive study with secondary data obtained from records of drug intoxications in680 children from zero to 12 years of age, in the National Health Surveillance System/Sinavisa, between 2012 and 2016. Data analysis was performed in IBM® SPSS Statistics®. Results: Children had a mean age of 2.9 years (standard deviation ± 2.3 years) and 50.1% were female. The events occurred mainly at home (95.4%), urban area (99.5%), through the digestive route (96.1%), accidentally (77.2%) and involving single acute exposure (99.6%). The average time between exposure and care was 8.1 hours. Care predominantly took place in a hospital (53.8%), in a public service (80.4%) and without hospitalization (71.9%). All intoxications were confirmed by clinical criteria. Most cases were of mild intensity (60.9%) and 98.7% evolved to cure. A variety of medicines resulted in intoxications (n=193), mainly drugs that act in the Central Nervous System. Conclusion: Drug intoxication in children predominantly happens in early childhood, due to domestic accidents, involving oral drugs, of the acute single type, and most of them evolve to cure. The care was predominantly hospital and in public units, and hospitalization was not necessary in most cases.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Revista Brasileira de Pesquisa em Saúde/Brazilian Journal of Health Research
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The Revista Brasileira de Pesquisa em Saúde (RBPS) adopts the CC BY 4.0 license, which means that authors retain the copyright of the works they submit to the journal. Authors are responsible for declaring that their contribution is an original manuscript, that it has not been previously published, and that it is not under simultaneous review by another scientific journal. Upon submitting the manuscript, authors grant RBPS the exclusive right of first publication, subject to peer review.
Authors are permitted to enter into additional contracts for the non-exclusive distribution of the version published by RBPS (for example, in institutional repositories or as a book chapter), provided that due acknowledgment of authorship and of initial publication by RBPS is given. Authors are also encouraged to make their work available online (for example, in institutional repositories or on their personal pages) after its initial publication in the journal, with due acknowledgment of authorship and of the original publication by RBPS.
Accordingly, under the CC BY 4.0 license, readers have the right to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially;
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
